Yeon Sook Choi
About Yeon Sook Choi
Yeon Sook Choi is an Associate Director at Sonata Therapeutics in Cambridge, Massachusetts, where she has worked since 2021. She has a robust background in pharmacology and oncology, with previous roles at Massachusetts General Hospital and Blueprint Medicines.
Work at Sonata Therapeutics
Yeon Sook Choi has served as Associate Director at Sonata Therapeutics since 2021. In this role, she is based in Cambridge, Massachusetts, and has been involved in various aspects of drug discovery and development, particularly focusing on oncology and targeted therapies. Her responsibilities include overseeing pharmacology studies and collaborating with multidisciplinary teams to advance therapeutic candidates.
Previous Positions in Research and Academia
Prior to her current role, Yeon Sook Choi held several significant positions in research and academia. She worked as an Instructor at Massachusetts General Hospital and Harvard Medical School from 2017 to 2019. She also served as a Senior Scientist I at Blueprint Medicines for a brief period in 2021, following her tenure as Scientist II at the same organization from 2019 to 2020. Her earlier roles include Research Associate at Massachusetts General Hospital from 2014 to 2017 and various postdoctoral fellowships at institutions such as the University of Pennsylvania and Korea University.
Education and Expertise
Yeon Sook Choi earned her Ph.D. in Life Science/Biotechnology from Korea University, where she studied from 1998 to 2002. Her educational background is complemented by extensive postdoctoral training in diverse fields, including oncology, cell biology, and molecular biology. This foundation has equipped her with the skills necessary to design and manage in vivo pharmacology studies and develop preclinical murine models that simulate human diseases.
Research Skills and Specializations
Yeon Sook Choi possesses a strong skill set in conducting pharmacology experiments, including efficacy, pharmacodynamic, pharmacokinetic, and tolerability studies using rodent cancer models. She has a proven track record in the discovery and evaluation of drug candidates, particularly in oncology. Her experience extends to supervising and mentoring team members, as well as collaborating with multidisciplinary teams across various scientific domains.
Professional Experience in Oncology and Drug Development
Throughout her career, Yeon Sook Choi has focused on oncology and targeted small molecule therapy. She has designed and managed both in-house and outsourced pharmacology studies, emphasizing the importance of developing preclinical models that accurately reflect human diseases. Her collaborative work with teams in Biology, DMPK, Drug Safety/Toxicology, and Chemistry highlights her comprehensive approach to drug discovery and development.